(VIANEWS) – NORBIT (NORBT.OL), SPAREBANKEN ØST (SPOG.OL), MELEXIS (MELE.BR) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. NORBIT (NORBT.OL)
33.5% sales growth and 19.45% return on equity
NORBIT ASA provides technology products and solutions. It operates through three segments: Oceans, Connectivity, and Product Innovation and Realization. The company designs and develops wideband multibeam sonars used for hydrographic and forward-looking applications, as well as for detection of advanced subsea leakage; and provides cable assemblies, electromechanical box builds, and business solutions. It also offers sensors and sensor platforms used for monitoring, detection, and reporting tasks; GuardPoint, a surveillance sonar used to detect underwater intruders; SafePoint that use to detect navigational obstacles; NORTrace, a software that simulates and graphs the underwater propagation of various sonar; SeaCOP software system for monitoring, detection, and emergency response for maritime and offshore operations; and security solutions for defense. In addition, the company provides high power underwater lights, power cabinets, and other sensor solutions for aquaculture industry. Further, it offers dedicated short-range communication (DSRC) technology for intelligent traffic systems and truck applications; global navigation satellite systems-based tolling and DSRC devices, and connectivity modules for smart tachographs; desktop readers; roadside units; and reclosable fasteners. The company was founded in 1980 and is headquartered in Trondheim, Norway.
Earnings Per Share
As for profitability, NORBIT has a trailing twelve months EPS of kr1.29.
PE Ratio
NORBIT has a trailing twelve months price to earnings ratio of 28.29. Meaning, the purchaser of the share is investing kr28.29 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.45%.
2. SPAREBANKEN ØST (SPOG.OL)
20.9% sales growth and 6.25% return on equity
Sparebanken Øst operates as a savings bank in Eastern Norway. The company offers financial products, such as savings, credit, and payment products; mortgages on homes; and debenture financing for second-hand cars, as well as services in the areas of financing, savings and investment, and money-transfer. It also distributes insurance, fund shares, interest rate hedging, and currency, as well as operates, manages, leases, and sells real estate properties. The company was founded in 1843 and is headquartered in Drammen, Norway.
Earnings Per Share
As for profitability, SPAREBANKEN ØST has a trailing twelve months EPS of kr6.62.
PE Ratio
SPAREBANKEN ØST has a trailing twelve months price to earnings ratio of 7.64. Meaning, the purchaser of the share is investing kr7.64 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.25%.
Moving Average
SPAREBANKEN ØST’s value is above its 50-day moving average of kr49.29 and higher than its 200-day moving average of kr48.85.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 30% and 71.3%, respectively.
3. MELEXIS (MELE.BR)
18.6% sales growth and 45.26% return on equity
Melexis NV designs, develops, tests, and markets advanced integrated semiconductor devices primarily for the automotive industry in Europe, the Middle-East, Africa, the Asia Pacific, and North and Latin America. The company provides magnetic position, latch and switch, current, inductive position, tire monitoring, temperature, optical, pressure, and speed sensor ICs. It also offers embedded motor driver, fan and pump, LED, and pre driver ICs; and LIN/CAN system basis, NFC/RFID, radio-frequency receiver and transmitter, and switch controller ICs. The company was founded in 1988 and is headquartered in Ieper, Belgium. Melexis NV is a subsidiary of Xtrion N.V.
Earnings Per Share
As for profitability, MELEXIS has a trailing twelve months EPS of €1.89.
PE Ratio
MELEXIS has a trailing twelve months price to earnings ratio of 54.12. Meaning, the purchaser of the share is investing €54.12 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 45.26%.
Yearly Top and Bottom Value
MELEXIS’s stock is valued at €102.50 at 21:20 EST, under its 52-week high of €106.40 and way higher than its 52-week low of €63.05.
Sales Growth
MELEXIS’s sales growth is 22.9% for the present quarter and 18.6% for the next.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is a negative 3.3% and positive 6.8% for the next.
4. BOIRON (BOI.PA)
17.3% sales growth and 9.87% return on equity
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.
Earnings Per Share
As for profitability, BOIRON has a trailing twelve months EPS of €2.86.
PE Ratio
BOIRON has a trailing twelve months price to earnings ratio of 14.3. Meaning, the purchaser of the share is investing €14.3 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.87%.
5. ROBERTET (RBT.PA)
14.1% sales growth and 14.34% return on equity
Robertet SA produces and sells perfumes, aromas, and natural products. The company operates in three segments: Raw materials, Fragrances, and Flavors. It also produces organic essential oils and active ingredients. The company operates in North America, Europe, the Asia Pacific, South America, Caribbean, Africa, and the Middle East. Robertet SA was founded in 1850 and is headquartered in Grasse, France.
Earnings Per Share
As for profitability, ROBERTET has a trailing twelve months EPS of €21.87.
PE Ratio
ROBERTET has a trailing twelve months price to earnings ratio of 39.55. Meaning, the purchaser of the share is investing €39.55 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.34%.
Volume
Today’s last reported volume for ROBERTET is 59 which is 79.65% below its average volume of 290.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Jun 29, 2022, the estimated forward annual dividend rate is 8 and the estimated forward annual dividend yield is 0.93%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 20.6%, now sitting on 667.32M for the twelve trailing months.
Sales Growth
ROBERTET’s sales growth is 14.1% for the current quarter and 14.1% for the next.
6. WALLENIUS WILHELMS (WAWI.OL)
12.4% sales growth and 21.73% return on equity
Wallenius Wilhelmsen ASA, together with its subsidiaries, provides roll-on roll-off (RoRo) shipping and vehicle logistics services worldwide. It operates through three segments: Shipping Services, Logistics Services, and Government Services. The company provides liner services through a fleet of approximately 50 modern and versatile RoRo vessels, which carry a mix of products, such as auto, construction, mining, agriculture machinery, and breakbulk products. It also offers inland transportation, supply chain management, and terminal services, as well as operates vehicle and equipment processing centres in key ports. The company provides its services principally under the Wallenius Wilhelmsen Ocean, Wallenius Wilhelmsen Solutions, EUKOR, ARC, Armacup, and Keen brands. The company serves agriculture, automotive, aviation, boats and yachts, breakbulk, commercial vehicles, construction, machinery and machine tools, mining, oil and gas, power and energy, and rail industries. It operates approximately 130 vessels servicing 15 trade routes. The company was founded in 1861 and is headquartered in Lysaker, Norway.
Earnings Per Share
As for profitability, WALLENIUS WILHELMS has a trailing twelve months EPS of kr-5.61.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.73%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 37%, now sitting on 4.77B for the twelve trailing months.
